CME: Crohn's Disease: Therapeutic Updates, Barriers to Care, and Emerging Therapies
ACCREDITATION EXPIRED: September 06, 2018
Activity Description / Statement of Need:
In this online CME self-learning program:
Inflammatory bowel disease (IBD) is a broad term that includes many different forms of inflammatory bowel conditions, the most common of which are Crohn’s disease and ulcerative colitis, the former of which affects any area of the alimentary canal. There are up to about fifteen new Crohn’s disease cases per 100,000 people per year, with the vast majority occurring in the North American continent, the United Kingdom (UK), and northern Europe.
Given the data from multiple studies that physicians are either not aware of updated practice guidelines or are not utilizing them and that this lack of knowledge is affecting patient satisfaction, CME programs are warranted to keep HCPs abreast of best practices. There have been many advances on both diagnostic and treatment sides, as well as a wide array of advances in care in pharmacotherapeutic options, including approved therapies as well as potential ones on the horizon, meriting CME.
Agenda:
- Faculty introduction, disclosures
- CD definition, symptomology
- Natural history
- Epidemiology
- Treatment: goals, ACG guidelines, mechanistic review and clinical trial evidence
- Salicylates
- Steroids
- Immunologics
- Biologics
- Optimizing medical treatment: therapeutic drug monitoring
- Surgery
- Barriers to care
- Risk of infection
- Malignancy
- Emerging therapies
- Summary
Target Audience:
Healthcare professionals specializing in: gastroenterology, internal medicine, or those who otherwise commonly care for patients with Crohn’s disease.
This program is supported by an educational grant from AMGEN
Release Date: September 06, 2016 -- Expiration Date: September 06, 2018
Faculty: Aline Charabaty, MD
Agenda
Learning Objectives
By the end of the session the participant will be able to:
- Describe the strengths and weaknesses of present and emerging diagnostic techniques, where applicable in Crohn�s disease.
- Describe strengths of different professional organizations� guidance in Crohn�s disease diagnosis and treatment guidelines
- Describe emerging therapies in the treatment of Crohn�s disease.
- Describe barriers to care in the treatment of Crohn�s disease and suggest ways to ameliorate them.
- Identify the present treatment options currently available for management of Crohn�s disease and apply them to patient cases using evidence-based medicine.
Accreditation
ACCREDITATION FOR THIS COURSE HAS EXPIRED. YOU MAY VIEW THE PROGRAM, BUT CME / CE IS NO LONGER AVAILABLE AND NO CERTIFICATE WILL BE ISSUED.
Faculty Disclosure and Resolution of COI
As a provider of continuing medical education, it is the policy of ScientiaCME to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, faculty and educational planners must disclose any significant relationships with commercial interests whose products or devices may be mentioned in faculty presentations, and any relationships with the commercial supporter of the activity. The intent of this disclosure is to provide the intended audience with information on which they can make their own judgments. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of ScientiaCME to ensure that the COI is resolved in order to ensure the integrity of the CME activity. For this CME activity, any COI has been resolved thru content review ScientiaCME.
Faculty Disclosure: Aline Charabaty, MD, Associate Professor of Medicine Director of the IBD Center MedStar Georgetown University Hospital, discloses financial support (research grant) from Abbvie.
Disclosures of Educational Planners: Charles Turck, PharmD is an officer and part owner of ScientiaCME, LLC.
Commercial Support Disclosure: This program is supported by an educational grant from AMGEN
Instructions
- Read the learning objectives above
- Take the Pre-Test (optional). Completion of the pre-test will help us evaluate the knowledge gained by participating in this CME activity.
- View the online activity. You may view this is in more than one session, and may pause or repeat any portion of the presentation if you need to.
- Minimum participation threshold: Take the post-test. A score of 70% or higher is required to pass and proceed to the activity evaluation.
- Complete the activity evaluation and CME registration. A CE certificate will be emailed to you immediately.
System Requirements
Windows 7 or above
Internet Explorer 8
*Adobe Acrobat Reader
Mac OS 10.2.8
Safari or Chrome or Firefox
*Adobe Acrobat Reader
Internet Explorer is not supported on the Macintosh
*Required to view Printable PDF Version
Please take a few minutes to participate in the optional pre-test. It will help us measure the knowledge gained by participating in this activity.
Additional Courses That Are Related To This Activity
Chronic Idiopathic Constipation (CIC): Optimizing Pharmacotherapeutic Management Strategies